Table 2.
Number of patients who developed CMV episode(s) within 12 months of transplant according to donor (D) and recipient (R) CMV serology
Pre-transplant CMV serology | Total number (%) | Number (%) of patients who developed CMV episode(s) | ||
---|---|---|---|---|
0 | 1 | ≥2 | ||
D−/R- | 58 (28%) | 55 (26.4%) | 1 (0.5%) | 2 (1.0%) |
D−/R+ | 59 (28.5%) | 28 (13.5%) | 19 (9.1%) | 12 (5.8%) |
D+/R- | 20 (9.5%) | 15 (7.2%) | 4 (1.9%) | 1 (0.5%) |
D+/R+ | 71 (34%) | 40 (19.2%) | 20 (9.6%) | 11 (5.3%) |
Total | 208 (100%) | 138 (66.4%) | 44 (21.2%) | 26 (12.5%) |